Inspira Technologies

Inspira Technologies is an innovative medical technology company in the respiratory care arena. Inspira was incorporated in 2018 with a clear mission: to develop a cost-effective, less-invasive respiratory support system as an alternative to invasive mechanical ventilation used today to save the lives of patients with acute respiratory failure. The company develops an early extracorporeal respiratory support system, The ART system, designed to elevate and stabilize patient oxygen saturation levels while the patient is awake and spontaneously breathing. The ART system is intended as an artificial assisting lung. It withdraws blood through a dual lumen cannula inserted into the jugular vein, enriches it with a high concentration of oxygen, removes CO2, and returns the enriched blood to rebalance patients’ saturation levels and take the load off the lungs.